Natalie Walker1, Trish Fraser2, Colin Howe1, Murray Laugesen3, Penny Truman4, Varsha Parag1, Marewa Glover5, Chris Bullen1. 1. National Institute for Health Innovation (NIHI), School of Population Health, The University of Auckland, Auckland, New Zealand. 2. Global Public Health Company Ltd, Glenorchy, New Zealand. 3. Health NZ Ltd, Christchurch, New Zealand. 4. Institute for Environmental Science and Research (ESR) Ltd, Porirua, New Zealand. 5. Centre for Tobacco Control Research, Social and Community Health, School of Population Health, The University of Auckland, Auckland, New Zealand.
Abstract
OBJECTIVE: To determine if smokers unmotivated to quit reduce usual cigarette consumption when cigarettes priced according to nicotine content are made available. METHODS: Randomised, parallel-group, trial (ACTRN12612000914864) undertaken in Wakatipu/Central Otago, New Zealand. Dependent adult daily smokers unmotivated to quit were randomly allocated to an intervention group provided with 12 weeks supply of free very low nicotine content (VLNC) cigarettes, or to a control group, who were free to purchase their usual cigarette brand over the same period. The primary outcome was change from baseline in the daily mean number of usual cigarettes smoked over the previous week, measured at 12 weeks. Secondary outcomes at 6 and 12 weeks included cigarettes smoked per week (also measured at weeks 1-6 and 9), salivary cotinine, tobacco dependence, smoking satisfaction/craving, behavioural addiction to smoking, autonomy over smoking, motivation to stop, price at which participants would purchase VLNC cigarettes, quitting and adverse events. RESULTS:Thirty-three smokers were randomised (17 intervention, 16 control). A NZ$15 price differential (per pack of 20) based on nicotine content led to a halving in the mean number of cigarettes smoked per day over the previous week, a reduction in tobacco dependence and an increase in quitting. Intervention participants smoked a similar total number of cigarettes (usual plus VLNC) as those in the control group, exposing them to a similar level of toxicants. CONCLUSIONS: Smokers unmotivated to quit reduce their usual cigarette consumption (and thus nicotine exposure) when VLNC cigarettes are made available at a significantly reduced price. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
RCT Entities:
OBJECTIVE: To determine if smokers unmotivated to quit reduce usual cigarette consumption when cigarettes priced according to nicotine content are made available. METHODS: Randomised, parallel-group, trial (ACTRN12612000914864) undertaken in Wakatipu/Central Otago, New Zealand. Dependent adult daily smokers unmotivated to quit were randomly allocated to an intervention group provided with 12 weeks supply of free very low nicotine content (VLNC) cigarettes, or to a control group, who were free to purchase their usual cigarette brand over the same period. The primary outcome was change from baseline in the daily mean number of usual cigarettes smoked over the previous week, measured at 12 weeks. Secondary outcomes at 6 and 12 weeks included cigarettes smoked per week (also measured at weeks 1-6 and 9), salivary cotinine, tobacco dependence, smoking satisfaction/craving, behavioural addiction to smoking, autonomy over smoking, motivation to stop, price at which participants would purchase VLNC cigarettes, quitting and adverse events. RESULTS: Thirty-three smokers were randomised (17 intervention, 16 control). A NZ$15 price differential (per pack of 20) based on nicotine content led to a halving in the mean number of cigarettes smoked per day over the previous week, a reduction in tobacco dependence and an increase in quitting. Intervention participants smoked a similar total number of cigarettes (usual plus VLNC) as those in the control group, exposing them to a similar level of toxicants. CONCLUSIONS: Smokers unmotivated to quit reduce their usual cigarette consumption (and thus nicotine exposure) when VLNC cigarettes are made available at a significantly reduced price. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
End game; Nicotine; Price; Public policy; Taxation
Authors: Katherine C Henderson; Emily E Loud; Hue Trong Duong; Reed M Reynolds; Bo Yang; Charity A Ntansah; David L Ashley; James F Thrasher; Lucy Popova Journal: Nicotine Tob Res Date: 2022-08-06 Impact factor: 5.825
Authors: Bryan W Heckman; K Michael Cummings; Georges J Nahas; Marc C Willemsen; Richard J O'Connor; Ron Borland; Alexander A Hirsch; Warren K Bickel; Matthew J Carpenter Journal: Nicotine Tob Res Date: 2019-05-21 Impact factor: 4.244
Authors: Natalie Nardone; Eric C Donny; Dorothy K Hatsukami; Joseph S Koopmeiners; Sharon E Murphy; Andrew A Strasser; Jennifer W Tidey; Ryan Vandrey; Neal L Benowitz Journal: Addiction Date: 2016-08-01 Impact factor: 6.526
Authors: Kirk Allen; Chris Kypridemos; Lirije Hyseni; Anna B Gilmore; Peter Diggle; Margaret Whitehead; Simon Capewell; Martin O'Flaherty Journal: BMC Public Health Date: 2016-04-01 Impact factor: 3.295